Report overview
Antibody, also called immunoglobulin, a protective protein produced by the immune system in response to the presence of a foreign substance, called an antigen. Antibodies recognize and latch onto antigens in order to remove them from the body. A wide range of substances are regarded by the body as antigens, including disease-causing organisms and toxic materials such as insect venom.
Treatment that uses antibodies to help the body fight cancer, infection, or other diseases. Antibodies are proteins made by the immune system that bind to specific markers on cells or tissues. IgG1 antibodies are a type of antibody made in the laboratory that can be used in diagnosis or treatment. In cancer treatment, IgG1 antibodies may kill cancer cells directly, they may block development of tumor blood vessels, or they may help the immune system kill cancer cells.
This report aims to provide a comprehensive presentation of the global market for Monoclonal Antibody Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Monoclonal Antibody Therapy. This report contains market size and forecasts of Monoclonal Antibody Therapy in global, including the following market information:
Global Monoclonal Antibody Therapy Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Monoclonal Antibody Therapy market was valued at US$ 117490 million in 2022 and is projected to reach US$ 186150 million by 2029, at a CAGR of 6.8% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The industry's leading producers are Roche, Abbvie and J & J, with revenues of 15.61%, 12.10% and 10.05% in 2019.
We surveyed the Monoclonal Antibody Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Monoclonal Antibody Therapy Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Monoclonal Antibody Therapy Market Segment Percentages, by Type, 2022 (%)
Human Monoclonal Antibody
Humanized Monoclonal Antibody
Chimeric Monoclonal Antibody
Murine Monoclonal Antibody
Global Monoclonal Antibody Therapy Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Monoclonal Antibody Therapy Market Segment Percentages, by Application, 2022 (%)
Cancer
Autoimmune Diseases
Others
Global Monoclonal Antibody Therapy Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Monoclonal Antibody Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Monoclonal Antibody Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Monoclonal Antibody Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbvie
Amgen
Glaxosmithkline
Merck
Novartis
Roche
Johson & Johson
Novartis
Outline of Major Chapters:
Chapter 1: Introduces the definition of Monoclonal Antibody Therapy, market overview.
Chapter 2: Global Monoclonal Antibody Therapy market size in revenue.
Chapter 3: Detailed analysis of Monoclonal Antibody Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Monoclonal Antibody Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
